Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.
about
Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patientsPrognostic significance of multiple kallikreins in high-grade astrocytoma.Kallikreins - The melting pot of activity and functionKallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.Kallikrein-related peptidases (KLKs) and the hallmarks of cancer.The brain tissue response to surgical injury and its possible contribution to glioma recurrence.Thrombin Activity and Thrombin Receptor in Rat Glioblastoma Model: Possible Markers and Targets for Intervention?Expression of Kallikrein-Related Peptidase 6 in Primary Mucosal Malignant Melanoma of the Head and Neck.Targeting the thrombin receptor modulates inflammation and astrogliosis to improve recovery after spinal cord injuryNeuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases.Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion.The Thrombin Receptor Restricts Subventricular Zone Neural Stem Cell Expansion and Differentiation.Kallikrein-related peptidase 6 orchestrates astrocyte form and function through proteinase activated receptor-dependent mechanisms
P2860
Q33581581-4B9DF8BB-B730-42D8-A1C5-A5192B3BA7B6Q33898338-D7D1C52E-82EF-4EDD-9430-4833F08D5D68Q33898347-58DBA7A2-AEED-40BE-A0E0-C5704B43DC41Q34087004-750E9BA4-FA7D-4257-8128-0C935FB03A9BQ35623800-A959C917-B960-432B-B9DC-77CEB4743146Q35732225-39F24AC8-CEBB-4508-B11E-D862AF83F6B0Q36563056-45CFB032-68C6-4B71-92F3-D45686F0E4CDQ37709144-F3CBB006-F113-43A5-AA91-73F8CD934AF8Q38737293-A16AAD4E-F51D-40CB-8D0E-2E54B618ADD5Q38767957-9E94ED61-F39A-4F95-897D-0930D142C320Q38908560-38F41F8E-4B03-4210-A577-3649B01918F1Q39187457-38B1FDA2-FDFE-4F11-9F96-895A069FD6A3Q41922463-34E34E51-CC96-4887-B7A6-6F4C90336696Q42696477-ACDDF310-B97A-4E39-8A2E-A6F4DB47FFD7Q55338815-9082F436-73AB-4673-A156-F351D112225DQ55403496-6B8BE761-2EED-44EC-813F-319544517118Q58699560-A0501532-CC3B-45A9-907A-44B2ADBD0AFC
P2860
Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.
@ast
Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.
@en
type
label
Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.
@ast
Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.
@en
prefLabel
Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.
@ast
Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.
@en
P2093
P2860
P356
P1433
P1476
Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.
@en
P2093
Alex R Paulsen
Brian P O'Neill
Caterina Giannini
Isobel A Scarisbrick
Joon H Uhm
Kristen L Drucker
Michael Blaber
Paul A Decker
Robert B Jenkins
Sachiko I Blaber
P2860
P304
P356
10.1093/NEUONC/NOS313
P577
2013-01-10T00:00:00Z